פנטאומיקס בע"מ

פנטאומיקס מפתחת מערכת דיאגנוסטיקה לסרטן אשר תעזור לפתולוגים לבצע אבחון מדויק ומהיר יותר, עם פחות רקמה.

A platform that provides detailed analysis at unprecedented accuracy with a proprietary hyper-spectral imager, based on a novel optical modality which allows its users to acquire the spectrum at each pixel of the sample in the range of 400-800nm during the scanning of the slide. The system’s integrated AI algorithms allow to put the complex biomarker maps extracted by the system into practical use. The system allows the unique combination of both spectral information, biomarker expression profiles, cell morphology features as well as overall cell distribution metrics, creating a unique vantage point.

Researchers and Pharma companies, Pathologists and Oncologists.

Boaz Brill - CEO & Co-Founder

Shmoolik Mangan - CTO